(Q53529879)

15 May 2018

title

Preparation and evaluation of (89)Zr-Zevalin for monitoring of (90)Y-Zevalin biodistribution with positron emission tomography. (English)

1 reference

15 May 2018

author name string

Lars R Perk

1

1 reference

15 May 2018

Otto J Visser

2

1 reference

15 May 2018

M Stigter-van Walsum

3

1 reference

15 May 2018

Maria J W D Vosjan

4

1 reference

15 May 2018

Gerard W M Visser

5

1 reference

15 May 2018

Josée M Zijlstra

6

1 reference

15 May 2018

Peter C Huijgens

7

1 reference

15 May 2018

Guus A M S van Dongen

8

1 reference

15 May 2018

publication date

11 July 2006

1 reference

15 May 2018

number of pages

9

1 reference

European Journal of Nuclear Medicine and Molecular Imaging

inferred from page(s)

published in

1 reference

15 May 2018

volume

33

1 reference

15 May 2018

issue

11

1 reference

15 May 2018

page(s)

1337-1345

1 reference

15 May 2018

https://scigraph.springernature.com/pub.10.1007/s00259-006-0160-0

exact match

0 references

cites work

(89)Zr as a PET surrogate radioisotope for scouting biodistribution of the therapeutic radiometals (90)Y and (177)Lu in tumor-bearing nude mice after coupling to the internalizing antibody cetuximab.

1 reference

12 December 2020

18FDG positron emission tomography versus 67Ga scintigraphy as prognostic test during chemotherapy for non-Hodgkin's lymphoma

1 reference

12 December 2020

The promise of immuno-PET in radioimmunotherapy

1 reference

12 December 2020

Quantitative 89Zr immuno-PET for in vivo scouting of 90Y-labeled monoclonal antibodies in xenograft-bearing nude mice

1 reference

12 December 2020

Determination of the immunoreactive function of radiolabeled monoclonal antibodies by linear extrapolation to binding at infinite antigen excess

1 reference

12 December 2020

Randomized controlled trial of yttrium-90-labeled ibritumomab tiuxetan radioimmunotherapy versus rituximab immunotherapy for patients with relapsed or refractory low-grade, follicular, or transformed B-cell non-Hodgkin's lymphoma.

1 reference

12 December 2020

Preclinical evaluation of 90Y-labeled anti-CD20 monoclonal antibody for treatment of non-Hodgkin's lymphoma

1 reference

12 December 2020

Monoclonal antibodies labeled with rhenium-186 using the MAG3 chelate: relationship between the number of chelated groups and biodistribution characteristics

1 reference

12 December 2020

Long-lived positron emitters zirconium-89 and iodine-124 for scouting of therapeutic radioimmunoconjugates with PET.

1 reference

12 December 2020

PET imaging of (86)Y-labeled anti-Lewis Y monoclonal antibodies in a nude mouse model: comparison between (86)Y and (111)In radiolabels.

1 reference

12 December 2020

89Zr immuno-PET: comprehensive procedures for the production of 89Zr-labeled monoclonal antibodies

1 reference

12 December 2020

Comparative biodistribution of indium- and yttrium-labeled B3 monoclonal antibody conjugated to either 2-(p-SCN-Bz)-6-methyl-DTPA (1B4M-DTPA) or 2-(p-SCN-Bz)-1,4,7,10-tetraazacyclododecane tetraacetic acid (2B-DOTA)

1 reference

12 December 2020

A phase 1/2 trial of high-dose yttrium-90-ibritumomab tiuxetan in combination with high-dose etoposide and cyclophosphamide followed by autologous stem cell transplantation in patients with poor-risk or relapsed non-Hodgkin lymphoma

1 reference

12 December 2020

High dose rhenium-186-labeling of monoclonal antibodies for clinical application: pitfalls and solutions.

1 reference

12 December 2020

Report of a European consensus workshop to develop recommendations for the optimal use of (90)Y-ibritumomab tiuxetan (Zevalin) in lymphoma.

1 reference

12 December 2020

Combining yttrium 90-labeled ibritumomab tiuxetan with high-dose chemotherapy and stem cell support in patients with relapsed non-Hodgkin's lymphoma.

1 reference

12 December 2020

Practical dosimetry of peptide receptor radionuclide therapy with (90)Y-labeled somatostatin analogs.

1 reference

12 December 2020

Treatment with ibritumomab tiuxetan radioimmunotherapy in patients with rituximab-refractory follicular non-Hodgkin's lymphoma

1 reference

12 December 2020

10.1007/S00259-006-0160-0

Identifiers

DOI

1 reference

15 May 2018

1 reference

15 May 2018